WDR83

WD repeat domain 83, the group of Spliceosomal P complex|WD repeat domain containing|Spliceosomal C complex

Basic information

Region (hg38): 19:12666802-12675832

Links

ENSG00000123154NCBI:84292OMIM:616850HGNC:32672Uniprot:Q9BRX9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the WDR83 gene.

  • not_specified (59 variants)
  • not_provided (18 variants)
  • Hypercholanemia,_familial (4 variants)
  • Neurodevelopmental_disorder_with_variable_familial_hypercholanemia (2 variants)
  • Attention_deficit_hyperactivity_disorder (1 variants)
  • Neurodevelopmental_disorder_with_seizures_and_speech_and_walking_impairment (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the WDR83 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001099737.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
missense
50
clinvar
2
clinvar
52
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 50 4 0

Highest pathogenic variant AF is 0.00000410444

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
WDR83protein_codingprotein_codingENST00000418543 99033
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
6.45e-120.03431256960521257480.000207
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.09781891930.9800.00001111995
Missense in Polyphen6769.5920.96275736
Synonymous0.4578085.40.9370.00000476648
Loss of Function-0.08431716.61.027.16e-7185

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004320.000420
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001090.000109
Finnish0.00009250.0000924
European (Non-Finnish)0.0001760.000176
Middle Eastern0.0001090.000109
South Asian0.0005230.000523
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Molecular scaffold protein for various multimeric protein complexes. Acts as a module in the assembly of a multicomponent scaffold for the ERK pathway, linking ERK responses to specific agonists. At low concentrations it enhances ERK activation, whereas high concentrations lead to the inhibition of ERK activation. Also involved in response to hypoxia by acting as a negative regulator of HIF1A/HIF-1-alpha via its interaction with EGLN3/PHD3. May promote degradation of HIF1A. May act by recruiting signaling complexes to a specific upstream activator (By similarity). May also be involved in pre-mRNA splicing. {ECO:0000250}.;
Pathway
EGF-Ncore;MAP2K and MAPK activation;Signal Transduction;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades (Consensus)

Intolerance Scores

loftool
0.444
rvis_EVS
-0.29
rvis_percentile_EVS
33.2

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.389
ghis
0.583

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.231

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Wdr83
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; immune system phenotype; embryo phenotype;

Gene ontology

Biological process
MAPK cascade;RNA splicing, via transesterification reactions;mRNA splicing, via spliceosome
Cellular component
spliceosomal complex;endosome membrane;catalytic step 2 spliceosome
Molecular function
protein binding